Based on our deep scientific understanding of NASH and rich experience in the discovery & development of various drugs, we have the ability to offer one-stop customizable services to help researchers bring new therapies to the market in a low-risk and time-saving manner.
NASH biomarkers will help pave the way for non-invasive diagnosis.
Learn MoreThere are currently no approved drug therapies for NASH. Our goal is to change that.
Learn MoreOur preclinical model services include in vivo and in vitro models that accurately mimic the pathology of NASH in humans.
Learn More